p53 Is a Helpful Marker in Distinguishing Langerhans Cell Histiocytosis From Langerhans Cell Hyperplasia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

p53 Is a Helpful Marker in Distinguishing Langerhans Cell Histiocytosis From Langerhans Cell Hyperplasia

Published:2017-10 Issue:10 Volume:39 Page:726-730
ISSN:0193-1091
Container-title:The American Journal of Dermatopathology
language:en
Short-container-title:

Author:

Grace Shane A.,Sutton Angela M.,Armbrecht Eric S.,Vidal Claudia I.,Rosman Ilana S.,Hurley Maria Y.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Dermatology,General Medicine,Pathology and Forensic Medicine

Reference23 articles.

1. Risk factors for diabetes insipidus in langerhans cell histiocytosis;Grois;Pediatr Blood Cancer.,2006

2. Aggressive histiocytic disorders that can involve the skin;Newman;J Am Acad Dermatol.,2007

3. “Pure” cutaneous histiocytosis-X;Wolfson;Cancer,1981

4. Differentiating skin-limited and multisystem Langerhans cell histiocytosis;Simko;J Pediatr.,2014

5. Immunohistochemical expression of Langerin in Langerhans cell histiocytosis and non-Langerhans cell histiocytic disorders;Lau;Am J Surg Pathol.,2008

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Langerhans Cell Hyperplasia Mimicking Langerhans Cell Histiocytosis: A Rare Complication of COVID-19 Vaccination;International Journal of Surgical Pathology;2023-11-09

2. Thyroid Langerhans cell histiocytosis concurrent with papillary thyroid carcinoma: A case report and literature review;Frontiers in Medicine;2023-01-19

3. Langerhans cell histiocytosis in adults: literature review;Oncohematology;2022-11-03

4. mRNA sequencing analysis and growth inhibitory effects of palbociclib on cell lines from canine histiocytic proliferative disorders;Veterinary and Comparative Oncology;2022-03-17

5. Cutaneous Pseudolymphoma With Langerhans Cell Hyperplasia—A Rare Case With Clinical Presentation Mimicking Malignancy and Potential Diagnostic Pitfall;The American Journal of Dermatopathology;2021-06-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3